Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice
Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. 13th Congress of European Crohn's and Colitis Organization, Vienna, February 2018
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. 13th Congress of European Crohn's and Colitis Organization, Vienna, February 2018
Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. 13th Congress of European Crohn's and Colitis Organization, Vienna, February 2018
Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. 13th Congress of European Crohn's and Colitis Organization, Vienna, February 2018
Treatment of pediatric Crohn's disease patients with early perianal complications
Adler J, Gadepalli S, Zacur G, Jarboe M, Dombkowski K. Treatment of pediatric Crohn's disease patients with early perianal complications. 2018 Crohn's & Colitis Congress, Las Vegas 2018
Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice
Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. ESPGHAN 51st Annual Meeting, Geneva 2018
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. ESPGHAN 51st Annual Meeting, Geneva 2018
Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. ESPGHAN 51st Annual Meeting, Geneva 2018
Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. ESPGHAN 51st Annual Meeting, Geneva 2018
Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry
Hensel K, Cunion D, Gasparetto M, Brennan M, Folan A, Lee C, Torrente F, Zilbauer M, Heuschkel R. Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry. ESPGHAN 51st Annual Meeting, Geneva 2018
Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice
Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. Digestive Diseases Week 2018, Washington, DC 2018
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. Digestive Diseases Week 2018, Washington, DC 2018
Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network
Schaefer M, Nelson A, Sanchez R. Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network. Digestive Diseases Week 2018, Washington, DC 2018
Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice
Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R, ImproveCareNow Network. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. Digestive Diseases Week 2018, Washington, DC 2018
Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. Digestive Diseases Week 2018, Washington, DC 2018
Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort
Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. Digestive Diseases Week 2018, Washington, DC 2018
Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry
Hensel K, Cunion D, Gasparetto M, Brennan M, Folan A, Lee C, Torrente F, Zilbauer M, Heuschkel R. Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry. ESPGHAN 51st Annual Meeting, Geneva 2018
Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure
Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. NASPGHAN Annual Meeting, Hollywood, FL 2018
Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease
Hoffenberg E, Murphy B, Mikulich-Gilbertson S, McWilliams S, Hoffenberg A, Hopfer C. Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease. NASPGHAN Annual Meeting, Hollywood, FL 2018
Outcomes in pediatric IBD patients not receiving immunological therapies
Benkov KJ, Serphos D. Outcomes in pediatric IBD patients not receiving immunological therapies. NASPGHAN Annual Meeting, Hollywood, FL 2018